Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shino Ohshima

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|January 1, 2020
Humanized Mice as an Effective Evaluation System for Peptide Vaccines and Immune Checkpoint InhibitorsYoshie Kametani, Yusuke Ohno, Shino Ohshima, et al.
Chemistry, an Asian Journal|October 9, 2019
Syntheses and Functional Studies of Self-Adjuvanting Anti-HER2 Cancer VaccinesQi Feng, Yoshiyuki Manabe, Kazuya Kabayama, et al.
Bioscience Trends|May 29, 2018
Expression of glucocorticoid receptor shows negative correlation with human B-cell engraftment in PBMC-transplanted NOGhIL-4-Tg miceToshiro Seki, Asuka Miyamoto, Shino Ohshima, et al.
Angewandte Chemie (International Ed. in English)|May 17, 2018
Syntheses and Immunological Evaluation of Self-Adjuvanting Clustered N-Acetyl and N-Propionyl Sialyl-Tn Combined with a T-helper Cell Epitope as Antitumor Vaccine CandidatesTsung-Che Chang, Yoshiyuki Manabe, Yukari Fujimoto, et al.
Veterinary Immunology and Immunopathology|May 30, 2012
Porcine MHC classical class I genes are coordinately expressed in superantigen-activated mononuclear cellsYoshie Kametani, Shino Ohshima, Yuki F Kita, et al.
Angewandte Chemie (International Ed. in English)|December 17, 2025
Programmable Antigen-Specific Immunity via Self-Adjuvanting Nanovaccines Co-Delivering Immune ModulatorsKeita Ito, Yoshiyuki Manabe, Shino Ohshima, et al.
RSC Advances|July 25, 2022
Precise immunological evaluation rationalizes the design of a self-adjuvanting vaccine composed of glycan antigen, TLR1/2 ligand, and T-helper cell epitopeTsung-Che Chang, Yoshiyuki Manabe, Keita Ito, et al.
Microbiology and Immunology|May 11, 2022
Coccomyxa sp.KJ extract affects the fate of T cells stimulated by toxic shock syndrome toxin-1, a superantigen secreted by Staphylococcus aureusShino Ohshima, Satoko Komatsu, Hirofumi Kashiwagi, et al.
Journal of the American Chemical Society|June 21, 2023
Antigen/Adjuvant-Displaying Enveloped Viral Replica as a Self-Adjuvanting Anti-Breast-Cancer Vaccine CandidateKeita Ito, Hiroto Furukawa, Hiroshi Inaba, et al.
Biochemistry and Biophysics Reports|April 19, 2024
Liposome-encapsulated progesterone efficiently suppresses B-lineage cell proliferationToshiro Seki, Rikio Suzuki, Shino Ohshima, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|January 1, 2020
Humanized Mice as an Effective Evaluation System for Peptide Vaccines and Immune Checkpoint InhibitorsYoshie Kametani, Yusuke Ohno, Shino Ohshima, et al.
Chemistry, an Asian Journal|October 9, 2019
Syntheses and Functional Studies of Self-Adjuvanting Anti-HER2 Cancer VaccinesQi Feng, Yoshiyuki Manabe, Kazuya Kabayama, et al.
Bioscience Trends|May 29, 2018
Expression of glucocorticoid receptor shows negative correlation with human B-cell engraftment in PBMC-transplanted NOGhIL-4-Tg miceToshiro Seki, Asuka Miyamoto, Shino Ohshima, et al.
Angewandte Chemie (International Ed. in English)|May 17, 2018
Syntheses and Immunological Evaluation of Self-Adjuvanting Clustered N-Acetyl and N-Propionyl Sialyl-Tn Combined with a T-helper Cell Epitope as Antitumor Vaccine CandidatesTsung-Che Chang, Yoshiyuki Manabe, Yukari Fujimoto, et al.
Veterinary Immunology and Immunopathology|May 30, 2012
Porcine MHC classical class I genes are coordinately expressed in superantigen-activated mononuclear cellsYoshie Kametani, Shino Ohshima, Yuki F Kita, et al.
Angewandte Chemie (International Ed. in English)|December 17, 2025
Programmable Antigen-Specific Immunity via Self-Adjuvanting Nanovaccines Co-Delivering Immune ModulatorsKeita Ito, Yoshiyuki Manabe, Shino Ohshima, et al.
RSC Advances|July 25, 2022
Precise immunological evaluation rationalizes the design of a self-adjuvanting vaccine composed of glycan antigen, TLR1/2 ligand, and T-helper cell epitopeTsung-Che Chang, Yoshiyuki Manabe, Keita Ito, et al.
Microbiology and Immunology|May 11, 2022
Coccomyxa sp.KJ extract affects the fate of T cells stimulated by toxic shock syndrome toxin-1, a superantigen secreted by Staphylococcus aureusShino Ohshima, Satoko Komatsu, Hirofumi Kashiwagi, et al.
Journal of the American Chemical Society|June 21, 2023
Antigen/Adjuvant-Displaying Enveloped Viral Replica as a Self-Adjuvanting Anti-Breast-Cancer Vaccine CandidateKeita Ito, Hiroto Furukawa, Hiroshi Inaba, et al.
Biochemistry and Biophysics Reports|April 19, 2024
Liposome-encapsulated progesterone efficiently suppresses B-lineage cell proliferationToshiro Seki, Rikio Suzuki, Shino Ohshima, et al.
Pageof 3